# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Hepatitis C
- **MONDO ID:**  (if available)
- **Category:** Infectious

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Hepatitis C**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-01-08T21:10:55.282499

1. galasso2024inflammatoryresponsein pages 8-9
2. lee2024hcvinducedautophagyand pages 3-5
3. mendezsanchez2024chronichepatitisc pages 4-5
4. smirne2024chronichepatitisc pages 6-8
5. smirne2024chronichepatitisc pages 5-6
6. mendezsanchez2024chronichepatitisc pages 1-2
7. sallam2024contemporaryinsightsinto pages 25-26
8. xiong2024keypointsfor pages 1-3
9. sallam2024contemporaryinsightsinto pages 4-5
10. brown2023exploringthemolecular pages 43-46
11. brown2023exploringthemolecular pages 49-51
12. moola2023restorationofsystemic pages 5-9
13. galasso2024inflammatoryresponsein pages 7-8
14. and
15. ing
16. https://doi.org/10.1073/pnas.2403392121;
17. https://doi.org/10.1186/s12985-024-02359-1;
18. https://doi.org/10.3389/fimmu.2024.1305157;
19. https://doi.org/10.3390/ijms25137191;
20. https://doi.org/10.3390/pathogens13040339;
21. https://doi.org/10.3390/ijms25147873;
22. https://doi.org/10.3390/v16121899;
23. https://doi.org/10.3389/fmicb.2024.1418301;
24. https://doi.org/10.3390/pathogens13040278;
25. https://doi.org/10.37349/edd.2024.00049;
26. https://doi.org/10.3390/microorganisms12061035;
27. https://doi.org/10.3389/fimmu.2024.1305157
28. https://doi.org/10.1073/pnas.2403392121
29. https://doi.org/10.1186/s12985-024-02359-1
30. https://doi.org/10.3390/ijms25137191
31. https://doi.org/10.3390/ijms25147873
32. https://doi.org/10.3390/pathogens13040339
33. https://doi.org/10.3390/pathogens13040278
34. https://doi.org/10.37349/edd.2024.00049
35. https://doi.org/10.3390/v16121899
36. https://doi.org/10.3389/fimmu.2024.1305157,
37. https://doi.org/10.3390/v16121899,
38. https://doi.org/10.3390/ijms25137191,
39. https://doi.org/10.3390/pathogens13040339,
40. https://doi.org/10.37349/edd.2024.00049,
41. https://doi.org/10.3390/microorganisms12061035,
42. https://doi.org/10.54014/4vbs-5jpp,
43. https://doi.org/10.14274/moola-archana\_phd2023,